|
Market Closed -
Warsaw S.E.
03:20:00 29/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 156.40 PLN | +3.30% |
|
+20.87% | +14.83% |
| 30/09 | Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 27/05 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 126M | - | - | - | - | - |
| 63.48B | |||||
| 54.55B | |||||
| 53.59B | |||||
| 44.75B | |||||
| 41.62B |
- Stock Market
- Stocks
- SCP Stock
- Charts Scope Fluidics S.A.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
